{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "57894-522",
      "generic_name": "AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)",
      "labeler_name": "Janssen Biotech, Inc.",
      "brand_name": "Rybrevant Faspro",
      "active_ingredients": [
        {
          "name": "AMIVANTAMAB",
          "strength": "3520 mg/22mL"
        },
        {
          "name": "HYALURONIDASE (HUMAN RECOMBINANT)",
          "strength": "44000 mg/22mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "57894-522-01",
          "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (57894-522-01)  / 22 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20260213",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Janssen Biotech, Inc."
        ],
        "rxcui": [
          "2729297",
          "2729304",
          "2729306",
          "2729307",
          "2735796",
          "2735797",
          "2735803",
          "2735804"
        ],
        "spl_set_id": [
          "9e58b045-e352-4f62-99bf-77fae1bebc69"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0357894522010"
        ],
        "nui": [
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_epc": [
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_cs": [
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "0JSR7Z0NB6",
          "743QUY4VD8"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION",
      "spl_id": "b4b42374-17ea-4cc5-8516-3f7731e71bf4",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20260213",
      "product_id": "57894-522_b4b42374-17ea-4cc5-8516-3f7731e71bf4",
      "application_number": "BLA761433",
      "brand_name_base": "Rybrevant Faspro",
      "pharm_class": [
        "Endoglycosidase [EPC]",
        "Glycoside Hydrolases [CS]"
      ]
    }
  ]
}